The life sciences sector is emerging into a new age.
As the next phase of the pandemic settles over the industry, a number of shifts have taken hold. Virtual work has become more common. A renewed emphasis on diversity and health equity has gained momentum. Clinical trials are becoming more patient-centric and more high-tech. Investments in women’s health have skyrocketed. And COVID-19 has not only become a part of our way of life — it’s become a long-term business imperative for pharma.
With all of these changes comes the need for transformative thinking in leadership.
Each year, our PharmaVoice 100 list salutes the trailblazers in the life sciences at the forefront of industry trends. They are standout leaders who go above and beyond the call of duty to push the industry forward while making a deep and lasting impact on their companies, colleagues, communities or scientific pursuits. They are pioneers who, for one reason or another — a love of science, a desire to help others, a brush with disease — have committed their careers and often their personal lives to serving patients.
So, here they are: Legacy Leaders. Disrupters. Entrepreneurs. Tech Wizards. DE&I Champions. Innovators.
These are the industry’s change-agents who are defining what excellence in leadership looks like in this next era.
Editor’s note: As always, selecting this year’s PharmaVoice 100 was no easy task. Thank you so much to the hundreds of nominators who wrote to us in support of their colleagues, friends, family members and the industry heroes who have inspired them. Nominations for the 2023 PharmaVoice 100 are open! Please send your submissions for our next class of honorees by April 1, 2023.
And don’t miss our list of 2022 Red Jacket honorees — the “hall of fame” winners from this year’s class of PharmaVoice 100s.
